SMPD3 and fatty liver disease: In conclusion, transcriptomic analysis of the livers from HFD-fed mice with liver steatosis identified a significant upregulation in Smpd3 (nSMase2), a key finding that led to the development of a HepG2 human cell model of induced steatosis by using glucolipotoxic stress conditions.